No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Packaged Foods
Clover Corporation Limited engages in the processing and worldwide sale of natural oils, reaching markets across Australia, New Zealand, Asia, Europe, and the Americas. The company's operations also encompass the creation of encapsulated products and extensive research and development focused on functional food and infant nutrition ingredients. Among its principal offerings are Nu-Mega Hi docosahexaenoic tuna oils, designed for use in infant formula and pharmaceutical goods, alongside its Ocean Gold refined tuna oils. Furthermore, it supplies Nu-Mega Driphorm powders, which are incorporated into various infant formulas, follow-on formulas, growing-up milks, and general food products, as well as Nu-Mega Driphorm HA for non-dairy applications. These products cater to several segments, including active living (for immune and sports support), healthy living (benefiting brain and heart health), and the foundational stages of infant and child development. The company, founded in 1988, maintains its corporate headquarters in Altona North, Australia.
www.clovercorp.com.auNo one on the platform currently holds CLV.AX.
No tracked institution reports a position in CLV.AX as of their last filing.
No one on the platform has traded CLV.AX yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 8.5% | 9.3% | 12.9% | — | — | — |
| Rev. Growth % | 38.3% | -0.5% | ||||
| Profit Margin % | 8.2% | 7.7% | 9.1% | |||
| Free Cash Flow Margin % | 8.1% | 8.3% | 5.2% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $116M | +23.5% | $0.08 | $0.08–$0.08 | — | 1 |
| 2028 | $139M | +19.4% | $0.10 | $0.10–$0.10 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 2 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-09-23 | $0.01 | $0.03 | +98.6% |
| 2022-09-14 | $0.10 | $0.03 | -69.2% |
| -1.19% |
| $85M |
| — |
| FRM.AXFarm Pride Foods Limited | $0.26 | +0.00% | $60M | — |
| LRK.AXLARK Distilling Co. Ltd. | $0.84 | +0.00% | $91M | — |
Source: Financial Modeling Prep · peers by sector/industry